Rabies is a viral infection that causes acute, progressive encephalitis and is considered to be universally fatal. However, during 2004, an unvaccinated Wisconsin patient received a new medical treatment and became the first documented survivor of rabies* who had not received preexposure vaccination or postexposure prophylaxis (PEP), suggesting the possibility of successful future interventions (1). This report describes two recent patients with rabies who were treated using therapy similar to that used for the Wisconsin patient; both treatments were unsuccessful. The report also describes the concomitant epidemiologic investigations by the Indiana State Department of Health (ISDH), California Department of Health Services (CDHS), and CDC, and the local public health responses in Marshall County, Indiana, and San Joaquin and Alameda counties in California. The findings in this report underscore the continuing need for enhanced clinical awareness of possible rabies exposure to ensure prompt PEP and timely diagnosis of rabies, especially if treatment is attempted.
Human Rabies -Indiana and California, 2006
Rabies is a viral infection that causes acute, progressive encephalitis and is considered to be universally fatal. However, during 2004, an unvaccinated Wisconsin patient received a new medical treatment and became the first documented survivor of rabies* who had not received preexposure vaccination or postexposure prophylaxis (PEP), suggesting the possibility of successful future interventions (1) . This report describes two recent patients with rabies who were treated using therapy similar to that used for the Wisconsin patient; both treatments were unsuccessful. The report also describes the concomitant epidemiologic investigations by the Indiana State Department of Health (ISDH), California Department of Health Services (CDHS), and CDC, and the local public health responses in Marshall County, Indiana, and San Joaquin and Alameda counties in California. The findings in this report underscore the continuing need for enhanced clinical awareness of possible rabies exposure to ensure prompt PEP and timely diagnosis of rabies, especially if treatment is attempted.
Indiana
Case report. On September 30, 2006, a girl aged 10 years had pain in her right arm, and her parents noticed a skin eruption on her trunk and extremities. On October 3, she began vomiting and had increased arm pain and occasional arm numbness. During her initial visit to her family's primary health-care provider on October 4, radiographs of her arm and clavicle were normal. Three to five days after her initial symptoms began, the patient's speech became difficult to understand, and she had a decreased appetite, sore throat and neck pain, and temperature of 101°F. She became irritable and agitated. A rapid Group A streptococcal antigen test and slide heterophil antibody assay were negative on October 6. The patient was hospitalized on October 7 at a community hospital, where she was found to have difficulty swallowing secretions. Her tongue had a whitish coating and was protruding from her mouth. Her complete blood count and electrolytes were normal. She was prescribed methylprednisolone for possible glossitis and fluconazole for mucosal candidiasis.
On October 8, neurologic involvement became more evident, and the attending physician arranged for transfer to a university-affiliated tertiary care pediatric hospital. On arrival at the pediatric hospital, the patient was irritable, with intermittent moments of alertness, altered mental status, and lethargy. She had slurred speech and difficulty swallowing secretions and complained of a drowning sensation. Because of difficulty breathing, low oxygen saturation, and excess secretions, the patient was intubated and placed on a mechanical ventilator. A lumbar puncture was performed, indicating a white blood cell (WBC) count of 26 cells/mm 3 (normal: 0-7 cells/mm 3 ), a red blood cell (RBC) count of 1 cell/mm 3 (normal: 0 cells/mm 3 ), a protein level of 28 mg/dL (normal: 15-45 mg/dL), and a glucose level of 89 mg/dL (normal: 40-70 mg/dL). Vancomycin, cefotaxime, and acyclovir were administered for the presumptive diagnosis of meningoencephalitis. On the second day of hospitalization, the patient experienced episodes of lethargy, somnolence, generalized skin flushing (associated with vancomycin administration), and hypersalivation.
Initial interviews of family members indicated that the patient frequently was exposed to healthy-appearing household cats and dogs but to no other animals. On the third day of hospitalization, the patient's primary-care physician told staff members at the pediatric hospital that a babysitter suggested the patient might have sustained an animal scratch or bite during June 2006. Family members did not know what type of animal might have scratched her. However, in spite of her endotracheal intubation, the patient was able to indicate that a bat had scratched or bit her. On the same day, serum, saliva, cerebrospinal fluid, and a skin biopsy from the nape of the neck (nuchal sample) were sent to CDC for rabies virologic testing, and a serum rabies-virus-specific antibody test was positive. Reverse transcription-polymerase chain reaction (RT-PCR) performed on saliva and skin samples also were positive for rabies virus amplicons, and direct fluorescent antibody (DFA) staining of the skin biopsy was positive for detection of rabies virus antigens. The patient had not received a rabies vaccine or rabies PEP.
After rabies was confirmed, the Wisconsin rabies treatment protocol (1) was initiated, including antiexcitatory and antiviral therapy with phenobarbital, midazolam, ketamine, and amantadine with aggressive supportive care. On the sixth day of hospitalization, ribavirin was administered intravenously, under a Food and Drug Administration (FDA) emergency use investigational new drug protocol. † Coenzyme Q10, L-arginine, tetrahydrobiopterin, and vitamin C also were administered in an attempt to replenish neurotransmitter substrates. During hospitalization, the patient experienced multiple complications, including increased intracranial pressure, bouts of diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), reversible pancreatitis secondary to ribavirin, intracranial venous sinus thrombosis, and cerebral and cerebellar herniation. In spite of a reduction in sedation drugs, the patient never regained consciousness. Because of a deteriorating clinical condition and poor prognosis, life support was withdrawn. The patient died on November 2, 2006, on the twenty-sixth day of hospitalization. Rabies virus antigen was detected in brain tissue collected postmortem.
Public health investigation. The patient's mother reported that in mid-June, the girl had awakened her during the night and said that a bird or bat had flown into her bedroom window and bitten her. The mother saw a small mark on the girl's arm, which the mother washed and treated with an over-thecounter first aid treatment. The mother then went to the girl's bedroom to see whether an animal was present. Finding none, she assumed that the incident was a nightmare, not uncommon for the girl. Approximately 2-3 days later, an older sibling took a dead bat away from the family cat; however, the mother did not associate this event with the previous incident and did not seek rabies PEP for the girl. The mother later reported that at the time of the incident, a bedroom window was probably open without a screen in place.
After genetic sequencing of amplicons obtained from the patient's skin and saliva, on October 14, CDC characterized the infecting agent as a rabies virus variant associated with the silver-haired bat, Lasionycteris noctivagans. ISDH recommended rabies PEP for persons who had been exposed to the patient's saliva, from 7 days before onset of initial symptoms through the time of her death. A total of 66 persons received PEP, including seven members of the patient's immediate family, a health-care worker at the patient's primary-care site, nine staff members at the first hospital in which she was treated, an ambulance service worker, 17 staff members at the pediatric hospital, and 31 persons from the patient's school and community.
California
Case report. On November 15, 2006, a boy aged 11 years had sore throat, fatigue, and fever (101°F). He was taken to his pediatrician's office on November 16 for a previously scheduled childhood vaccination related to his recent immigration from the Philippines on October 2, 2006. He received a diagnosis of pharyngitis and was prescribed amoxicillin; the vaccinations were deferred. That evening, the boy was taken to a hospital emergency department (ED) with chest tightness, dysphagia, and insomnia. He had tachycardia (128 beats/min) and hypertension (148/99 mmHg) but no fever; his respiratory rate and oxygen saturation level were normal.
During the next several hours in the ED, the boy experienced irregular lip and mouth movements, hallucinations, and agitation. Rabies-associated signs such as aerophobia, hydrophobia, profuse salivation, and copious oral secretions were noted, and he was transported to a tertiary care pediatric hospital. Because the possibility of rabies was raised by providers at the referring hospital, infection-control measures were initiated at the pediatric hospital, including contact and droplet precautions.
The patient was admitted to the pediatric intensive care unit (PICU). He had profuse salivation and required tracheal intubation, and he experienced intermittent altered mental status. In the ED and subsequently in the PICU, the patient experienced hemodynamic instability associated with sedative administration, and he required cardiac resuscitation. An electrocardiogram showed sinus tachycardia with diffuse ST-T wave changes, and an echocardiogram indicated high systemic vascular resistance and secondary cardiomyopathy. A lumbar puncture indicated a WBC count of 8 cells/mm 3 , RBC count of 0 cells/mm 3 , a protein level of 25 mg/dL, and a glucose level of 128 mg/dL. On the basis of the patient's history, clinical signs, and symptoms, he received ketamine and midazolam infusions on the first hospital day for control of dysautonomia, as described in the Wisconsin rabies treatment protocol (1) . § Overnight, after consultation with the California Department of Health Services (CDHS), samples were obtained for rabies diagnosis, including corneal impressions, cerebrospinal fluid, serum, and saliva. On the second hospital day, the samples were sent to CDC and the CDHS Viral and Rickettsial Disease Laboratory. Rabies virus antigens were detected in the corneal impressions by DFA on November 18. After receiving this result, physicians from the hospital consulted with CDHS, CDC, and the physicians who developed the Wisconsin protocol therapy, and intravenous ribavirin and enteral amantidine, tetrahydrobiopterin, and coenzyme Q10 were administered.
The patient's family was asked about possible animal exposures. Although the parents were unaware of any specific incidents, two siblings recalled that the patient had been bitten by a dog approximately 2 years previously, when he was living in the Philippines. He did not receive rabies PEP at that time.
At CDC, rabies virus RNA was detected by RT-PCR in patient saliva samples obtained on the third hospital day. The gene sequences were similar to those of a canine rabies virus variant from the Philippines. Rabies virus antigen was detected by DFA in a nuchal biopsy that was obtained on the fourth hospital day. Serology for detection of rabies virus antibodies was performed daily by an indirect immunofluorescent assay and was negative until the twelfth hospital day, when an immunoglobulin G (IgG) titer of 1:128 was detected. The following day, the serum IgG titer increased to 1:256, and the immunoglobulin M (IgM) titer was 1:10. Rabies virus IgG was first detected in the cerebrospinal fluid on the fourteenth hospital day, with a titer of 1:8. A repeat nuchal biopsy was performed on the twentieth hospital day to assess viral clearing; rabies virus antigen was detected, but the staining intensity was less prominent and had a less organized pattern than the previous biopsy.
The patient experienced multiple complications while hospitalized, including autonomic lability, SIADH, renal insufficiency, superficial thrombophlebitis of the left lower extremity, cerebral artery spasm, subclinical seizures, mild pan- creatic enzyme elevation attributed to ribavirin, and progressive heart block requiring transvenous pacing. Cerebral perfusion was monitored daily via transcranial Doppler. Additional anticonvulsant therapy was initiated on the eighteenth hospital day because of seizures. A continuous electroencephalogram (EEG) indicated bursts of electrical brain activity followed by little brain activity (i.e., burstsuppression pattern), and by the twenty-first hospital day indicated that almost no brain activity remained. Transcranial Doppler sonography results remained within normal limits.
On the twenty-fourth hospital day, the patient had diabetes insipidus, and the EEG indicated almost no electrical brain activity. A cranial computed tomography scan on the same day indicated loss of differentiation of the grey-white boundary of the brain and diffuse cerebral edema. Transcranial Doppler sonography indicated a high resistive index with no diastolic flow. Midazolam infusion was discontinued. After discussions between the family and the care team, life support was withdrawn on December 13, the twenty-seventh hospital day, and the patient died. Rabies virus antigen was detected in brain tissue collected postmortem.
Public health investigation. To identify exposures to the patient and the need for rabies PEP among identified contacts, CDHS distributed rabies assessment tools (which vary according to exposure scenario) to the public health department in San Joaquin County, where the patient first became ill, and in Alameda County, the location of the pediatric hospital. All 13 members of the patient's family were identified as potentially exposed because they had shared food and drink with the patient and reported contact with the patient's saliva; all received PEP. None of the three staff members at the primary-care physician's office or two emergency-transport personnel were determined to require PEP. Health-care workers at the hospital in San Joaquin County were interviewed, and eight of 22 elected to begin PEP because of potential contact with saliva. No additional interventions were deemed necessary in San Joaquin County. Twenty-four health-care workers were interviewed at the pediatric hospital in Alameda County. Three received PEP for potential exposure to saliva through mucous membranes or uncovered breaks in the skin.
Editorial Note: During 2000-2006, a total of 19 of the 24 human rabies cases reported in the United States were acquired indigenously (2) . The history of exposure to a bat given by the patient in Indiana described in this report and the identification of a specific bat rabies virus variant support the explanation of indigenous rabies acquisition via bat bite. In contrast, the history of a dog bite in the patient from California described in this report, even though the bite occurred years before his immigration to the United States, suggests acquisition of rabies in the Philippines; this is supported by isolation and identification of a specific canine-associated rabies virus variant found in the Philippines. Typical rabies incubation periods vary from 1 to 3 months after exposure, but longer intervals have been documented (3) .
Human rabies is preventable with proper wound care and timely, appropriate administration of human rabies immune globulin and rabies vaccine before onset of clinical symptoms (4) . PEP is recommended for all persons who have been bitten or scratched by an animal suspected to have rabies virus and for all persons whose mucous membranes have been exposed to the virus.
Twenty-seven health-care workers received PEP as part of the investigations in Indiana and California. Previous reports have described administration of PEP to contacts of humans with rabies (5). The indications for PEP among health-care workers who care for patients with rabies include exposure of mucous membranes or open wounds to infectious body fluids or tissue (e.g., saliva, tears, cerebrospinal fluid, or neurologic tissue) from the patient. Adherence to standard infection-control precautions minimizes the risk for healthcare workers' exposure to rabies (4) .
During 2004, the first documented survival of a patient who had not received preexposure vaccination or rabies PEP occurred in a patient from Wisconsin. Treatment for this patient included an intensive protocol that included druginduced coma and administration of antiviral drugs (1). However, the benefits of any particular experimental regimen have not been determined, and no single specific course of therapy for rabies in humans has been demonstrated effective after clinical signs manifest (6) .
Rabies is usually a fatal illness in humans. To consider use of the Wisconsin rabies treatment protocol, the disease must be diagnosed as early in the course as possible, which requires enhanced clinical awareness of the disease among health-care providers. Rabies should be included in the differential diagnosis of any unexplained acute, rapidly progressive viral encephalitis. Although initial signs and symptoms of rabies are nonspecific, a history of an animal bite or travel to a rabiesindigenous country, combined with clinical signs such as paresthesia, hypersalivation, dysphagia, hydrophobia or aerophobia, behavioral changes, or sudden autonomic instability, should lead to a strong suspicion of rabies. Rapid diagnosis of rabies virus infection can be beneficial to the treatment of the patient and can facilitate appropriate prophylaxis for exposed persons. In addition to current measures, other national and international interventions are needed to raise awareness, improve health education, expand diagnostic testing, and improve rabies prevention, control, and treatment.
In addition to its use as a nutritional supplement, niacin (nicotinic acid or vitamin B3) is medically prescribed to treat hyperlipidemia and hypercholesterolemia. Use of niacin in low doses usually leads to few adverse drug reactions (ADRs); however, at larger doses, niacin can cause skin flushing, itching, and occasionally more serious effects (1 Among the 18 persons who said their ADRs resulted from nonsuicidal, intentional, nonmedical use of niacin, the median age, excluding three adults of unknown ages, was 18 years (range: 15-50 years). Eight of the 18 persons said they took niacin (1,000 mg-8,000 mg) to alter or mask a drug screening; eight others said they took niacin (400 mg-5,000 mg) to "purify, cleanse, or flush" their bodies; and two said they used niacin as a diet pill. Among the 18 persons who gave no reason for niacin use, eight were aged <30 years, and two patients of unknown age reported taking a 2,000-mg dose and "large amounts" of niacin, respectively; under the case definition, those 10 persons were categorized as possible users of niacin to defeat urine drug testing.
Editorial Note: Niacin is well established as a medical treatment for hyperlipidemia (3) and available by prescription in 50-mg to 500-mg tablets or capsules. The initial recommended therapeutic daily dose is 100 mg, three times a day, titrated to a maximum daily dose of 1,000 mg (4). Extended-release niacin tablets and capsules (at 125 mg-1,000 mg) also are available by prescription, usually in a dose of 500 mg at bedtime, to a maximum of 2,000 mg per day. The therapeutic use of niacin often is limited by dermatologic and gastrointestinal ADRs (e.g., tachycardia, flushing, rash, nausea, vomiting, or abdominal pain). These effects usually are self-limited and are more common with dosages >1,000 mg per day, but can occur at any dose. Hepatotoxicity is a rare but serious adverse effect, usually associated with chronic use (5) .
No scientific evidence indicates that taking niacin can alter a urine drug test result. However, readily accessible information on the Internet lists ingestion of niacin as a way to prevent detection of tetrahydracannabinol (THC), the main psychoactive ingredient of marijuana. An Internet search on the words "niacin" and "marijuana" can produce tens of thousands of results.
In addition to sales as a prescription drug, niacin is sold over the counter (in 100-mg to 500-mg tablets) and generally is regarded as a safe nutritional supplement with well-known dermatologic and gastrointestinal ADRs that usually are selflimited and resolve with supportive care (1). Death from acute overdose has not been reported, and a minimum lethal dose has not been established (6) . However, severe effects in some patients have been reported. A report in press on use of niacin to defeat urine drug tests describes four cases of niacin toxicity that included hepatotoxicity, metabolic acidosis, variations in blood glucose, neutropenia, and electrocardiographic effects (7) . Two of the four patients had life-threatening ADRs; one had taken 5,500 mg of niacin during a 36-hour period, and the other had taken 2,500 mg during a 48-hour period.
The findings in this report are subject to at least four limitations. First, the data were collected retrospectively from the RMPDC database; although a specific data set was gathered for each case, persons might have misrepresented the circumstances of their niacin use, leading to misclassification, underreporting of dosages, or inaccurate reporting of symptoms. Second, persons who did not cite a reason for using niacin and were aged <30 years and persons who took more than 1,000 mg or "large amounts" of niacin were categorized as possible users of niacin to alter drug test results; however, those persons might have used niacin for other reasons, including treatment of hyperlipidemia. Third, poison center data might not be representative of all niacin exposures; patients with less severe or no symptoms from niacin use would not contact a poison center. Finally, RMPDC is a regional poison center, and the use of niacin to attempt to alter or mask drug test results might be a regional phenomenon. Further research of national poison center data can provide additional information regarding nonmedical use of niacin.
Public health measures such as school-based education and authoritative Internet communications might help prevent ADRs if directed at those who are prompted to misuse niacin by claims that are not substantiated scientifically. This report underscores the importance of taking medications in appropriate doses and for approved indications as directed by a health-care provider. With the Internet now a common source of medical information, clinicians can expect to encounter patients with unusual ADRs resulting from nonscientific drug use (8) and should familiarize themselves with these effects and counsel their patients accordingly.
Hypothermia-Related MortalityMontana, 1999-2004
Hypothermia, defined as a core body temperature of <95°F (35°C), occurs in persons exposed to excessive cold. Although hypothermia can be fatal, it also is preventable. Risk factors for death from hypothermia include advanced age, substance abuse, altered mental status, and increased contact with substances that promote heat loss, such as water (1) . Montana has an intensely cold and long winter. In December, the average daily minimum temperature is approximately 18.0°F (-7.7°C) and can remain at that level until March. For the entire year in Montana, the average daily minimum temperature is 35.9°F (2.2°C) (2) . During the period 1999-2004, Montana had the second highest (after Alaska) average annual hypothermia-related mortality rate (1.08 deaths per 100,000 population) in the United States, approximately five times greater than the U.S. rate overall. This report describes three examples of case reports of hypothermia-related deaths in Montana during 2005-2006, summarizes hypothermiarelated mortality in the state during 1999-2004 (the most recent period for which annual data were available), and discusses hypothermia risk factors and prevention measures. Enhanced education and intervention strategies, particularly targeted to older adults, might reduce the number of deaths from hypothermia in Montana.
Case Reports
Case 1. In November 2005, a man aged 88 years left home to work in the fields. When he did not return for dinner, his wife notified a neighbor, who found the man pinned at the thighs between a flatbed trailer and livestock panels. The man was in pain and said he was cold; he had diminished level of consciousness. The ambient air temperature was 47.0°F (8.3°C) with 13-mph winds. The man was extricated by the neighbor and brought to the hospital. He had moderate muscle stiffness and was unable to respond to commands. His core body temperature was 84.7°F (29.3°C). The patient died 2 days later in the hospital. Primary cause of death was severe hypothermia; secondary causes were crush injuries to the thighs and multiorgan failure.
Case 2. In November 2005, a man aged 49 years left his automobile in a wooded area to go deer hunting just before sunset. He became lost in a forest and walked 6 miles across rugged and mountainous terrain. While he was missing, ambient temperatures ranged from 28.0°F to 40.0°F (-2.2°C to 4.4°C). A mixture of wet rain and snow fell during the night and most of the next day. Search crews tracked him and found him the next night, 30 hours after he had left his vehicle. The man was found dressed in thermal underwear, jeans, wool socks, sneakers, a cotton shirt, an oil-cloth coat, and a cowboy hat. All of his clothing was wet, and he smelled of wood smoke. He was carrying his rifle and a global positioning system unit. Trackers determined that the man had stumbled and fallen several times. When found, the man was unresponsive and cyanotic; his body was stiff, and he had no detectable respiration or pulse. After several hours of backcountry transport, the man was pronounced dead. The coroner certified death as fatal arrhythmia resulting from severe hypothermia.
Case 3. In February 2006, a woman aged 43 years attempted to drive home late at night down a little-traveled road. When she did not arrive home, her husband looked for her along the road but could not find her in the dark and assumed she had spent the night in town. Ambient air temperatures that night ranged between -10.0°F and -15.0°F (-23.3°C to -26.1°C). The woman was found the next morning by a rancher who noticed her car, which had gone off the road and down a steep embankment after she had apparently missed a sharp turn. She was found dead in her car. On autopsy, she had no significant traumatic injuries but a blood alcohol concentration of 0.15 g/dL, nearly twice the state legal limit of 0.08 g/dL for drivers. Cause of death was hypothermia. (Table) . Thirty-one (53%) victims were aged >65 years, and 20 (34%) were aged 45-64 years. Because fewer than 20 hypothermia deaths were recorded in Montana each year, producing statistically unreliable annual hypothermia-related death rates, an aggregate crude rate was calculated by combining data for the entire period 1999-2004. Montana's 59 deaths during that period produced a crude rate for hypothermia-related mortality of 1.08 per 100,000 population, approximately five times greater than that of the United States as a whole (3,881 deaths, for a crude rate of 0.23 per 100,000 population) (Table) . Editorial Note: This report supports previous U.S. findings that persons aged >65 years and males are at greater risk for death by hypothermia (1, 4) . Older age might be a risk factor because of lower metabolic rate, which in turn might prevent maintaining a normal body temperature when indoor or outdoor temperatures fall below 64.4°F (18.0°F) (1). In addition, alcohol consumption is a risk factor because it triggers increased heat loss via vasodilation (5). Alcohol and drugs also can alter a person's mental status, impairing behavioral responses and increasing the risk for exposure to cold. Contact with cold water or other substances that promote heat loss also can cause hypothermia through conduction (the transfer of heat via contact with a cooler object) (5). Although only one person aged <15 years died from hypothermia in Montana during the study period, populations at risk for hypothermia also can include very young children and persons with comorbid medical conditions. These persons might have difficulty regulating their body temperature, thus increasing their risk for hypothermia (6) . Hypothermia is classified as mild, moderate, or severe, as determined by core body temperature (5) . In severe cases of hypothermia, the brain is affected and victims are unable to think clearly or move well, which can further exacerbate their exposure. Warning signs of hypothermia in adults are shivering, exhaustion, confusion, fumbling hands, memory loss, slurred speech, and drowsiness (7) .
Hypothermia-Related Mortality, 1999-2004
During periods of excessively cold weather, persons can reduce their risk for hypothermia by taking the following precautions: 1) covering exposed skin and wearing a hat to prevent heat loss, 2) avoiding overexertion that might cause sweating and increased cardiac stress, 3) wearing loose-fitting layers of clothing that trap heat close to the body, 4) avoiding consumption of alcohol and other drugs that can impair judgment, and 5) staying dry by avoiding contact with cold substances that promote heat loss (8) . In addition, persons living or traveling in cold environments can reduce their risk for hypothermia by preparing a winter storm plan, assembling a disaster supplies kit, being aware of storm warnings and the wind chill factor, leaving a travel itinerary with a friend or family member, carrying a cellular telephone, and avoiding travel during winter storms (9) . Enhanced public health education and community intervention strategies might reduce the risk for hypothermia in persons at greatest risk.
Brief Report
Gastroenteritis Among Attendees at a Summer Camp -Wyoming, June-July 2006
On July 19, 2006, the Environmental Protection Agency (EPA) notified the Wyoming Department of Health (WDH) of an Escherichia coli-positive well-water sample, indicating fecal contamination, that had been submitted from a Wyoming summer youth camp after the camp manager noticed cases of gastroenteritis among campers and staff members. This report describes the subsequent investigation by WDH, the Wyoming Department of Agriculture (WDA), and the Wyoming Department of Environmental Quality (WDEQ), which identified Norovirus and Campylobacter species as the etiologic agents. WDH staff contacted camp managers on July 19; the following day, WDA, WDEQ, and WDH jointly conducted an on-site investigation of the camp, which was located in a mountainous region of southeastern Wyoming. The preliminary investigation suggested a waterborne mechanism of transmission. The camp usually operated during May-September only, typically hosting campers for approximately 1 week. In 2006, the facility had opened in May for adult weekend retreats, and a longer adult retreat was held during mid-June. No illnesses were reported at either time. The first campers to experience illness were children who attended camp during the week of June 25-July 1, 2006 (Figure) . Onset of illness for the first laboratory-confirmed case of Norovirus was July 1, 2006. Additional groups arrived at the camp during each of the following 3 weeks. The number of weekly camp attendees ranged from 29 to 73. The age range of attendees was 7 to 65 years,* although typical groups were composed of adult staff members and campers who were adolescent boys or girls.
Active case finding and surveillance began after WDH was notified of the E. coli-positive well-water sample. Activities included ascertaining the extent of the outbreak, confirming that the camp was the source of exposure, and interviewing all ill persons among camp attendees. Laboratory testing of fecal samples from symptomatic attendees was conducted to confirm the outbreak etiology. In addition, public-health nursing offices were contacted in the home towns of campers, Health Alert Network (HAN) faxes were sent to health-care providers throughout Wyoming, and both Epi-X and the foodborne disease listserv operated by CDC were used to identify ill campers residing in other states. The camp voluntarily closed on July 19 as recommended by WDH until improvements in the camp's water and septic systems could be implemented.
A case was defined as an illness lasting more than 24 hours that included three or more episodes of diarrhea, vomiting, or both, in a camper or staff member after arriving at or leaving the camp during June 1-July 19, 2006. Lists of camp attend-* Excludes a child aged 2 years, who was the child of a staff member. ees were obtained from camp managers, and a retrospective cohort study was conducted by administering a telephone questionnaire to 210 of 277 (75.8%) campers and staff members. Two wells provided the camp with water, which was not treated before use. The wells were 30-50 feet deep, 25 feet apart, and approximately 120 feet from an underground metal septic tank that had been installed in the 1950s. Although these distances comply with the Wyoming State Engineer's Office guidelines for appropriate distancing of wells and septic systems, the guidelines emphasize that minimum distances are site dependent, should take into account local geology, and must be professionally evaluated before the required septic-tank construction permits are issued. The septic tank was filled to capacity when observed during site visits on July 20 and August 3 and had not been maintained adequately over the years. The system did not have a properly constructed leach field (i.e., soil absorption area), and the ground immediately downhill from the tank was damp with sewage. Food-preparation areas had been inspected by WDA before this outbreak investigation and were in compliance with WDA regulations. Well-water samples collected on July 20 were positive for E. coli. WDEQ and WDH investigators inspected the camp again on August 3, approximately 2 weeks after the camp's closure. Well-water samples collected from the camp at this time were tested at CDC and were negative for both Campylobacter and Norovirus by culture and PCR. However, the 2-week delay from camp closure to sample collection might have limited the laboratory's ability to isolate the pathogens from the water system because uncontaminated groundwater might have replenished the aquifer. Septic system contents tested positive for Norovirus genogroups 1 and 2. Five fresh fecal samples obtained from cattle kept in the area surrounding the camp also were cultured at WPHL. A C. jejuni isolate was identified in one of the samples; however, the PFGE patterns did not match those obtained from campers.
The investigators determined that although the camp met established EPA criteria defining community water sources and although it had not been subject previously to periodic EPA monitoring, the camp's water system should be regulated as a public water system. WDH and WDEQ advised camp directors to remove the septic tank and have a new system installed in an appropriate location, as determined through a professional site evaluation, to decrease the likelihood of future well-water contamination. Installation of either an ultraviolet or a chlorination disinfection unit also was recommended for additional protection. After system improvements have been completed and certified as compliant with EPA regulations, the camp's water system will be subject to periodic EPA testing guidelines and evaluated for coliforms, turbidity, and nitrate content.
This outbreak of gastroenteritis at a summer camp in Wyoming was caused by Norovirus and C. jejuni, which were simultaneously identified in stool samples from ill campers. The investigation emphasizes that multiple etiologic agents should be considered when waterborne disease is suspected and might be related to sewage or septic contamination. A similar outbreak of gastrointestinal illness involving C. jejuni and Norovirus was associated with sewage-contaminated groundwater in Ohio (1), and a waterborne outbreak of Norovirus was reported at a summer church camp in Norway (2). Other recent outbreaks at U.S. summer camps were caused by person-to-person transmission of Norovirus (3).
Investigators of the outbreak described in this report hypothesized that the large number of camp attendees overburdened the septic system and created a heavy demand for water from the wells, thereby reducing the groundwater level and allowing septic system effluent to contaminate the water that replenished the wells. The shallowness of the wells and their proximity to the septic tank, combined with the camp's location in a mountainous area with fractured rock aquifers and little topsoil, also might have facilitated contamination by allowing septic tank effluent to percolate to the wells through fissures in the underlying rock formations. An ongoing drought in the area likely was an additional contributing factor that permitted changes in groundwater levels, facilitating contamination. Such factors were identified in a similar outbreak in Wyoming (4), suggesting that alternative waste water treatment methods might be necessary where geologic conditions warrant.
Public health officials, health-care providers, and waterquality regulators should be aware of the potential for septic contamination of well water at rural summer camp sites that lack appropriate water and septic systems. In addition, before sending their children to a summer camp, parents should inquire about recent water-quality testing in the camp, particularly if it is located in a rural area where similar systems are more likely to be encountered.
Notice to Readers

United Nations Global Road Safety Week -April 23-29, 2007
Each year 1.2 million persons (vehicle drivers, passengers, and pedestrians) die on the world's roads; 40% of these deaths occur among persons aged <25 years. This year, the first United Nations Global Road Safety Week will be held in an attempt to improve road safety by increasing awareness of these preventable deaths and by promoting interventions that have had the greatest impact on road safety (e.g., safety belts, road design, helmets, and prohibitions on drinking and driving and speeding). The first Global Road Safety Week is dedicated to younger road users (1) . In the United States, the focus is on teen drivers aged 16-19 years, whose risk for motor vehicle crash is four times greater than that for older drivers (2) . Two of five deaths among U.S. teens are the result of a motor vehicle crash (3).
The World Health Organization has produced a toolkit to guide activities related to Global Road Safety Week (1). Other governmental and nongovernmental organizations are participating in various ways. Additional information is available at CDC (http://www.cdc.gov/ncipc/duip/grsw), the National Highway Traffic Safety Administration (http://www.nhtsa.dot. gov), and Make Roads Safe (http://www.makeroadssafe.org). 
Notice to Readers
National Infant Immunization WeekApril 21-28, 2007
The week of April 21-28, 2007, is National Infant Immunization Week (NIIW) and Vaccination Week in the Americas (VWA). During this week, hundreds of communities throughout the United States are expected to participate in NIIW-VWA by sponsoring activities emphasizing the importance of timely infant and childhood vaccination.
Immunization is one of the most effective ways to protect infants and children from potentially serious diseases. Approximately 11,000 infants are born each day in the United States; according to the recommended immunization schedule, each infant requires approximately 27 doses of vaccine (i.e., administered in 21 or 22 injections of combination vaccines) before age 2 years for protection from 14 vaccine-preventable diseases (1).
Kick-off events highlighting the need to achieve and maintain high childhood vaccination coverage rates will be hosted in Nevada; Colorado; Hidalgo County, Texas; and communities along the U.S.-Mexico border. Events will include education activities for providers, media events, and immunization clinics in collaboration with CDC, state and local health departments, the United States-Mexico Border Health Commission, and the Pan American Health Organization (PAHO).
NIIW is being held in conjunction with VWA. VWA, sponsored by PAHO, targets children and other vulnerable and underserved populations with low vaccination coverage rates in all countries in the Western hemisphere.
During NIIW-VWA, CDC has English-and Spanishlanguage public education campaign materials available to communities, including television public service announcements, posters, print advertisements, articles, and educational materials for parents and providers. Additional information about NIIW-VWA and childhood vaccination is available from CDC at http://www.cdc.gov/nip/events/niiw/default.htm. Information on VWA is available at http://www.paho.org/ English/DD/PIN/vw_2007.htm. 
Notice to Readers
Africa Malaria Day and Malaria Awareness Day -April 25, 2007
Malaria is a preventable and treatable parasitic disease that continues to cause at least 1 million deaths worldwide each year, with approximately 90% of these deaths occurring among young children in Africa (1). On April 25, 2000, government leaders from 44 African countries met in Abuja, Nigeria, and signed the Abuja Declaration, committing their countries to decreasing malaria deaths in Africa by 50% by 2010 (2). Since then, April 25 has been commemorated as Africa Malaria Day (AMD) worldwide. This year's theme, Free Africa from Malaria NOW!, is a reminder of the effects of malaria and underscores the possibility that current measures might soon reduce the burden of malaria in Africa. This year, April 25 also marks the first Malaria Awareness Day in the United States, declared at the White House Summit on Malaria in December 2006.
The fight against malaria recently received renewed commitment and resources. The Global Fund to Fight AIDS, Tuberculosis, and Malaria (GF), founded in 2002, is the largest source of funding for malaria control, providing two thirds of all international financing. GF has approved $2.6 billion in grants over 5 years to programs in 85 countries. Of this, $698 million has been disbursed to 33 countries in subSaharan Africa.
On AMD 2005, the World Bank pledged $500 million in a 3-year intensive first phase to accelerate progress against malaria in Africa through its Global Strategy and Booster Program for Malaria Control, which aims to strengthen program design and implementation, increase intervention coverage, and improve outcomes. As of AMD 2007, the bank has committed $357 million, benefiting 14 countries in Africa. In addition, other programs and groups (e.g., Nothing But Nets, a grassroots campaign of the United Nations Foundation and partners, and Malaria No More, a nonprofit organization) were recently created and collaborate with other organizations that address malaria in Africa.
QuickStats from the national center for health statistics from the national center for health statistics from the national center for health statistics from the national center for health statistics from the national center for health statistics
Percentage of All Live Births by Cesarean DeliveryNational Vital Statistics System, United States, 2005
Preliminary data for 2005 indicate that 30.2% of all live births in the United States were cesarean deliveries, marking the highest U.S. total cesarean rate ever reported. Since 1996, the total cesarean rate has increased by 46%, driven by both an increase in the percentage of all women having a first cesarean and a decline in the percentage of women delivering vaginally after a previous cesarean. Cesarean rates vary considerably among states but tend to be lower in the western mountain states and upper Midwest region and higher in the Southeast and East regions. SOURCE: National Vital Statistics System, unpublished data. Additional information is available at http:// www.cdc.gov/nchs/births.htm. -19  44  120  282  102  109  259  1,459  1,419  1  2  12  22  36  Connecticut  -5  25  48  56  25  42  203  465  461  -0  7  15  8  Maine§   -4  14  41  20  -2  8  20  39  1  0  4  4  5  Massachusetts  -0  18  -146  60  47  96  764  698  -0  7  -19  New Hampshire  -0  9  1  1  5  3  9  45  64  -0  3  3  -Rhode Island§   -0  17  -15  10  10  19  149  139  -0  3  -1  Vermont§   -3  12  30  44  2  1  5  16  18  -0  2 2  3  13  37  20  81  80  142  1,169  1,303  -0  2  2  2  Louisiana  -1  6  22  -17  184  366  2,319  2,805  -0  3  4  1  Oklahoma  2  2  11  29  20  36  107  237  1,600  1,000  -1  24  28  21  Texas§   N  0  0  N  N  203  576  931  7,246  8,203  -0  2  2  1   Mountain  15  30  68  343  373  37  269  455  2,417  3,947  3  4  14  94  85  Arizona  3  3  11  53  32  22  106  220  648  1,338  3  2  9  47  31  Colorado  -10  26  116  131  -71  93  524  1,016  -1  4  20  26  Idaho§   6  3  12  32  44  10  2  20  74  61  -0  1  3  3  Montana§   -2  11  19  18  1  3  20  27  38  -0  0  --Nevada§   -1  9  25  29  -31  135  534  669  -0  2  5  6  New Mexico§   -1  6  21  17  -30  65  395  501  -0  2  9  10  Utah  6  7  27  68  96  4  16  28  197  272  -0  3  10  9  Wyoming§   -1  4  9  6  -2  5  1 8  5 2  -0  1  --Pacific  44  60  147  821  801  379  783  971 10,660 11,935  2  2  8  35  30  Alaska  -1  17  16  8  3  11  27  120  157  -0  2  4  3  California  32  43  71  598  610  303  645  833  9,059  9,901  -0  6  -9  Hawaii  2  1  4  17  17  1  15  30  164  306  -0  1  1  5  Oregon§   7  9  14  114  110  30  26  46  315  391  2  1  6  30  12  Washington  3  8  68  76  56  42  75  131  1,002  1,180  -0  2  -1 American Rico  3  5  19  45  26  5  6  16  106  98  -0 7  15  52  195  405  3  12  38  167  148  -1  11  25  34  Alaska  -0  1  1  1  1  0  3  3  1  -0  1  --California  4  13  48  175  377  2  8  26  129  114  -1  11  20  34  Hawaii  -0  2  2  6  -0  1  -2  -0  0  --Oregon§   -1  3  9  1 1  -2  5  2 6  2 3  -0  0  --Washington  3  1  4  8  10  -1  12  9  8  -0  2 2  22  255  65  90  -0  6  3  9  -1  3  7  14  Connecticut  -9  227  20  47  -0  3  -1  -0  2  2  3  Maine§   -2  39  12  17  -0  1  3  2  -0  3  2  2  Massachusetts  -0  3  -19  -0  3  -5  -0  2  -9  New Hampshire  2  5  97  27  2  -0  3  ---0 -0  3  1  1  -0  2  1  3  -0  2  3  3  Kentucky  -0  2  ---0  1  1  1  -0  1  1  3  Mississippi  -0  1  ---0  1  1  1  -0  3  3  3  Tennessee§   -0  2  5  -1  0  2  5  2  1  0  2  8  6 W.S. Central  -1  6  1 0  2  -1  7  3  1 1  -1  9  3 3  2 9  Arkansas§   -0  0  ---0  2  ---0  2  5  5  Louisiana  -0  1  2  --0  1  1  1  -0  4  9  4  Oklahoma  -0  0  ---0  2  1  1  -0  3  7  5  Texas§   -1  6  8  2  -1  6  1  9  -0  9  1 2  1 5 3  3  17  42  28  1  4  14  26  50  5  5  11  85  125  Alaska  -0  1  2  --0  4  2  4  -0  1  1  2  California  3  3  14  35  28  1  2  6  19  39  2  3  9  58  83  Hawaii  N  0  0  N  N  -0  2  ---0  2  2  4  Oregon§   -0  2  5  --0  3  4  4  2  0  3  1 1  1 8  Washington  -0  3  ---0  11  1  3  1  0  5  13  18 American Samoa -1  13  2  14  -0  5  7  7  -0  10  -3  Louisiana  -0  2  5  3  -0  0  ---0  1  --Oklahoma  -0  9  -2  -0  9  10  11  -0  18  --Texas†   -14  134  80  155  -0  29  -197  -0  6  -1   Mountain  40  37  75  362  958  -3  28  16  34  -0  5  1  1  Arizona  30  6  26  91  178  -2  10  15  31  -0  2  --Colorado  -8  26  96 386 -0  2  6  4  California  31  89  218  881  851  1  0  5  27  N  12  28  81  228  345  Hawaii  -5  16  52  60  -0  3  3  3  -1  3  10  10  Oregon§   1  7  17  64  104  2  1  9  9  15  -1  6  13  56  Washington  1  11  83  101  88  2  2  22  10  8  10  2  13  28  45 American Samoa 3  2  7  52  80  -0  3  9  14  15  14  29  214  162  Alabama§   N  0  0  N  N  -0  0  --8  5  17  73  79  Kentucky  1  0  2  11  20  -0  1  1  3  1  1  9  25  20  Mississippi  -0  0  ---0  0  ---2  8  34  17  Tennessee§   2  2  7  4 1  6 0  -0  3  8  1 1  6  5  1 2  8 2  4 6 W.S. Central  -1  6  47  8  -0  2  5  3  15  29  58  402  401  Arkansas§   -0  3  1  4  -0  0  -2  2  1  7  3 1  2 7  Louisiana  -1  2  17  4  -0  1  2  1  5  5  30  82  55  Oklahoma  -0  5  29  --0  2  3  --1  5  25  22  Texas§   -0  0  ---0  0  --8  21  31  264  297   Mountain  -1  5  1 8  4 2  -0  5  6  1 9  -8  2 7  5 8  1 2 8  Arizona  -0  0  ---0  0  ---2  16  11  58  Colorado  -0  0  ---0  0  ---1  5  3 -0  0  ---0  0  --6  37  52  401  577  Alaska  -0  0  ---0  0  ---0  2  3  5  California  N  0  0  N  N  -0  0  --2  34  49  356  499  Hawaii  -0  0  ---0  0  ---0  1 461  200  966  3,833  3,652  -0  58  -2  -0  26  -1  Arkansas¶   1  11  92  170  313  -0  4  ---0  2  --Louisiana  -2  11  41  20  -0  13  ---0  9  -1  Oklahoma  -0  0  ---0  6  ---0  4  --Texas¶   460  172  873  3,622  3,319  -0  38  -2  -0  16  --Mountain  23  57  102  1,006  1,244  -0  61  ---1  228  --Arizona  -0  0  ---0  9  ---0  15  --Colorado  -22  51  370  646  -0  10  ---0 U  --U  U  U  --U  U  U  --U  U  Guam  ---------------Puerto Rico  11  12  30  155  149  -0  0  ---0 
United States
147 310 994 3,507 4,139 2,764 6,848 8,674 82,710 97,340 35 43 141 671 678
New England
Samoa U 0 0 U U U 0 2 U U U 0 0 U U C.N.M.I. U - - U U U - - U U U - - U U Guam - - - - - - - - - - - - - - - Puerto2 - - U.S. Virgin Islands U 0 0 U U U 0 3 U U U 0 0 U U- 0 3 - 1 - 0 0 - - - 0 1 - - Nevada § - 0 2 3 5 - 1 5 1 2 1 2 - 0 2 2 3 New Mexico § - 0 2 1 6 - 0 2 4 5 - 0 2 2 - Utah - 0 2 2 7 - 0 4 8 3 - 0 2 5 4 Wyoming § - 0 1 - 1 - 0 1 - - - 0 1 2 - Pacific5 - American Samoa U 0 0 U U U 0 0 U U U 0 0 U U C.N.M.I. U - - U U U - - U U U - - U U Guam - - - - - - - - - - - - - - - Puerto Rico 1 1 10 14 13 1 1 9 12 5 - 0 1 - - U.S. Virgin Islands U 0 0 U U U 0 0 U U U 0 0 U U
- 0 2 - 1 - 0 1 2 - - 0 1 1 5 North Dakota - 0 0 - - - 0 1 - 1 - 0 1 1 1 South Dakota - 0 1 - - - 0 0 - 1 - 0 1 1 - S.Mountain - 0 4 2 3 - 1 6 1 0 1 8 1 1 4 3 1 3 0 Arizona - 0 2 - 3 - 0 3 4 3 1 0 3 9 9 Colorado - 0 1 - - - 0 2 4 6 - 0 2 8 10 Idaho § - 0 2 - - - 0 1 - - - 0 1 2 1 Montana § - 0 1 1 - - 0 1 1 1 - 0 1 1 - Nevada § - 0 1 1 - - 0 1 - - - 0 1 3 3 New Mexico § - 0 1 - - - 0 1 - 1 - 0 1 1 1 Utah - 0 1 - - - 0 2 1 7 - 0 2 6 4 Wyoming § - 0 1 - - - 0 0 - - - 0 2 1 2
Pacific
U 0 0 U U U 0 0 U U U 0 0 - - C.N.M.I. U - - U U U - - U U U - - - - Guam - - - - - - - - - - - - - - - Puerto Rico N 0 0 N N - 0 1 1 - - 0 1 3 2 U.S. Virgin Islands U 0 0 U U U 0 0 U U U 0 0 - -† 1- 0 0 - - - 0 1 - - Idaho † - 1 7 1 1 2 6 - 0 2 4 - - - 0 3 1 - Montana † - 1 8 1 0 3 5 - 0 2 - 2 - 0 2 - - Nevada † - 0 9 3 1 5 - 0 1 - - - 0 1 - - New Mexico † - 2 8 1 3 2 5 - 0 2 - 1 - 0 2 - 1 Utah 10 10 50 126 275 - 0 1 1 - - 0 0 - - Wyoming † - 1 8 1 2 1 8 - 0 2 - - - 0 1 - -- 0 0 - - N 0 0 N N American Samoa U 0 0 U U U 0 0 U U U 0 0 U U C.N.M.I. U - - U U U - - U U U - - U U Guam - - - - - - - - - - N - - N N Puerto Rico - 0 1 - - - 1 6 15 28 N 0 0 N N U.S. Virgin Islands U 0 0 U U U 0 0 U U U 0 0 U U 2U 0 0 U U U 0 0 U U U 0 0 U U C.N.M.I. U - - U U U - - U U U - - U U Guam - - - - - N - - N N - - - - - PuertoN 0 0 N N N 0 0 N N Nevada § - 0 1 1 1 - 0 0 - - New Mexico § - 1 4 1 9 3 0 - 0 4 1 1 9 Utah 1 1 7 45 21 - 0 0 - - Wyoming § - 0 1 2 2 - 0 0 - -
E.S. Central
W.S. Central
